Recent research suggests a role for the hypothalamic-pituitary-adrenal (HPA) axis in the behavioral effects of cocaine. Cocaine induces glucocorticoid release (e.g., corticosterone, ACTH) probably due to corticotropin releasing factor (CRF). In general, treatments that increase levels of these hormones enhance some behavioral effects of cocaine, whereas treatments that decrease levels of these hormones attenuate some of these effects. This includes stressor exposure that activates the HPA axis and amplifies the behavioral effects of cocaine. And, greater behavioral responsivity to cocaine has been related to inherently high HPA axis hormone levels. Inherent differences in HPA axis function exist between two inbred strains, lewis and Fischer 344 (F344) rats, which also differ in their behavioral and biochemical responses to psychoactive drugs. Lewis rats, compared to F344 rats, exhibit enhanced sensitivity to and preference for cocaine. These strains also differ in several biochemical characteristics of the mesolimbic dopamine system, a neural area associated with drug responses. Paradoxically, Lewis rats have blunted HPA hormonal activity and impaired autoimmune responses. That HPA axis hormones interact with the immune system (e.g., ACTH induces release of some cytokines) may have important implications for the relationship of immunological diseases, such as HIV infection, and cocaine abuse. This grant will compare how various manipulations of the HPA axis (e.g., glucocorticoid administration adrenalectomy, CRF antiserum and antagonist administration, stress exposures) affect the neurobehavioral responses to cocaine in Lewis and F344 rats; these strains provide models both to study interactions of the neuroendocrine and immune systems and to study vulnerability to drug abuse. Behavioral measures will include locomotor activity, place conditioning, drug discrimination, and self-administration. Biochemical measures will include many signal transduction proteins (e.g, tyrosine hydroxylase, protein kinase A) regulated specifically in VTA/NAcc by chronic drug or stress exposure. In addition, levels of ACTH-related cytokines will be assessed. These studies may provide insight into possible differing etiologies and treatment approaches for cocaine abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA004060-13
Application #
6103953
Study Section
Project Start
1998-12-01
Project End
2000-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
13
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Bradberry, Charles W (2011) Cortical and sub-cortical effects in primate models of cocaine use: implications for addiction and the increased risk of psychiatric illness. Neurotox Res 19:235-42
Greenwell, Thomas N; Martin-Schild, Sheryl; Inglis, Fiona M et al. (2007) Colocalization and shared distribution of endomorphins with substance P, calcitonin gene-related peptide, gamma-aminobutyric acid, and the mu opioid receptor. J Comp Neurol 503:319-33
Kosten, Thomas R; Scanley, Barbara Ellen; Tucker, Karen A et al. (2006) Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 31:644-50
Abi-Saab, Danielle; Beauvais, John; Mehm, John et al. (2005) The effect of alcohol on the neuropsychological functioning of recently abstinent cocaine-dependent subjects. Am J Addict 14:166-78
Kosten, Thomas R; Tucker, Karen; Gottschalk, P Christopher et al. (2004) Platelet abnormalities associated with cerebral perfusion defects in cocaine dependence. Biol Psychiatry 55:91-7
Tucker, Karen A; Browndyke, Jeffrey N; Gottschalk, P Christopher et al. (2004) Gender-specific vulnerability for rCBF abnormalities among cocaine abusers. Neuroreport 15:797-801
Kosten, Thomas R; Kosten, Therese A (2004) New medication strategies for comorbid substance use and bipolar affective disorders. Biol Psychiatry 56:771-7
Tucker, Karen A; Potenza, Marc N; Beauvais, John E et al. (2004) Perfusion abnormalities and decision making in cocaine dependence. Biol Psychiatry 56:527-30
Browndyke, Jeffrey N; Tucker, Karen A; Woods, Steven P et al. (2004) Examining the effect of cerebral perfusion abnormality magnitude on cognitive performance in recently abstinent chronic cocaine abusers. J Neuroimaging 14:162-9
Kosten, Thomas R; Gottschalk, P Christopher; Tucker, Karen et al. (2003) Aspirin or amiloride for cerebral perfusion defects in cocaine dependence. Drug Alcohol Depend 71:187-94

Showing the most recent 10 out of 188 publications